Home › Compare › CLKTF vs JNJ

CLKTF vs JNJ: Dividend Comparison 2026

CLKTF yields 20000000.00% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CLKTF wins by $4.875981653489057e+49M in total portfolio value
10 years
CLKTF
CLKTF
● Live price
20000000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.875981653489057e+49M
Annual income
$48,759,336,949,911,260,000,000,000,000,000,000,000,000,000,000,000,000,000.00
Full CLKTF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — CLKTF vs JNJ

📍 CLKTF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCLKTFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CLKTF + JNJ cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
CLKTF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CLKTF
Annual income on $10K today (after 15% tax)
$1,700,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$41,445,436,407,424,570,000,000,000,000,000,000,000,000,000,000,000,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, CLKTF beats the other by $41,445,436,407,424,570,000,000,000,000,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CLKTF + JNJ for your $10,000?

CLKTF: 50%JNJ: 50%
100% JNJ50/50100% CLKTF
Portfolio after 10yr
$2.4379908267445285e+49M
Annual income
$24,379,668,474,955,630,000,000,000,000,000,000,000,000,000,000,000,000,000.00/yr
Blended yield
100.00%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

CLKTF
No analyst data
Altman Z
-11.8
Piotroski
1/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CLKTF buys
0
JNJ buys
0
No recent congressional trades found for CLKTF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCLKTFJNJ
Forward yield20000000.00% ✓3.36%
Annual dividend / share$2.00$4.96 ✓
Payout ratio50% ✓55%
1-year div growth0%4.2% ✓
5-year div CAGR0%5.8% ✓
Portfolio after 10y$4.875981653489057e+49M$20.0K ✓
Annual income after 10y$48,759,336,949,911,260,000,000,000,000,000,000,000,000,000,000,000,000,000.00 ✓$827.78
Total dividends collected$4.875978515990276e+49M$5.6K ✓
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CLKTF vs JNJ ($10,000, DRIP)

YearCLKTF PortfolioCLKTF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$2,000,010,700$2,000,000,000.00$10,676$355.77+$2000.00M → CLKTF
2$373,835,915,712,384$373,833,775,700,934.50$11,407$389.39+$373835915.70M → CLKTF
3$65,304,953,364,964,970,000$65,304,553,360,535,160,000.00$12,198$426.53+$65304953364964.96M → CLKTF
4$10,661,728,832,755,500,000,000,000$10,661,658,956,455,399,000,000,000.00$13,056$467.62+$10661728832755499008.00M → CLKTF
5$1,626,767,783,781,495,000,000,000,000,000$1,626,756,375,731,643,800,000,000,000,000.00$13,987$513.12+$1.626767783781495e+24M → CLKTF
6$231,974,330,054,625,100,000,000,000,000,000,000$231,972,589,413,096,470,000,000,000,000,000,000.00$14,998$563.56+$2.319743300546251e+29M → CLKTF
7$30,915,106,403,922,057,000,000,000,000,000,000,000,000$30,914,858,191,388,900,000,000,000,000,000,000,000,000.00$16,098$619.52+$3.0915106403922057e+34M → CLKTF
8$3,850,507,985,839,278,000,000,000,000,000,000,000,000,000,000$3,850,474,906,675,425,000,000,000,000,000,000,000,000,000,000.00$17,295$681.69+$3.8505079858392777e+39M → CLKTF
9$448,210,261,035,314,200,000,000,000,000,000,000,000,000,000,000,000$448,206,140,991,769,400,000,000,000,000,000,000,000,000,000,000,000.00$18,599$750.82+$4.4821026103531426e+44M → CLKTF
10$48,759,816,534,890,570,000,000,000,000,000,000,000,000,000,000,000,000,000$48,759,336,949,911,260,000,000,000,000,000,000,000,000,000,000,000,000,000.00$20,022$827.78+$4.875981653489057e+49M → CLKTF

CLKTF vs JNJ: Complete Analysis 2026

CLKTF — Stock

CalciTech Ltd. develops and commercializes synthetic calcium carbonate (SCC) in Europe. It produces SCC from waste lime and air polluting carbon dioxide. SCC is a white pigment that is used in various industrial applications, including paper, polymers, paints, foods, and pharmaceuticals. The company offers three SCC products targeting the paper industry, which comprise CalciLS, which is designed to maximize light scattering; CalciSG that is designed to provide a gloss coating for premium grade printing and writing papers; and CalciRG, a performance-enhancing additive targeted at the rotogravure market. It also provides CalciSP, a non-paper product targeted at the food, pharmaceutical, and cosmetics industries; and CalciRC, which is targeted at polymer applications, such as plastics, sealants, rubber, and adhesives. The company was formerly known as Kemgas Ltd. and changed its name to CalciTech Ltd. in July 2000 to reflect change in business to the production and sale of SCC. CalciTech Ltd. was founded in 1978 and is based in Geneva, Switzerland.

Full CLKTF Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this CLKTF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CLKTF vs SCHDCLKTF vs JEPICLKTF vs OCLKTF vs KOCLKTF vs MAINCLKTF vs ABBVCLKTF vs MRKCLKTF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.